ID

15781

Beschreibung

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01689662

Link

https://clinicaltrials.gov/show/NCT01689662

Stichworte

  1. 13.06.16 13.06.16 -
Hochgeladen am

13. Juni 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Metastatic Renal Cell Carcinoma NCT01689662

Eligibility Metastatic Renal Cell Carcinoma NCT01689662

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. subject must be 18 years of age or older.
Beschreibung

subjects must meet the following eligibility requirements to be enrolled in the study.

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
2. subject must have known or strongly suspected metastatic renal cell carcinoma with at least one target lesion as identified by ultrasonography, mri, or ct.
Beschreibung

metastatic renal cell carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0278678
3. subject must have good kidney function.
Beschreibung

kidney function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232804
4. subject must provide written informed consent prior to enrollment.
Beschreibung

written informed

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. subject is pregnant or breastfeeding.
Beschreibung

subjects must be excluded if any of the following conditions are present:

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
2. subject is simultaneously participating in another investigational drug study, excluding the follow-up phase.
Beschreibung

participating in another study

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
3. subject has received an investigational agent within 7 days prior to enrollment.
Beschreibung

investigational agent

Datentyp

boolean

Alias
UMLS CUI [1]
C1875319
4. subject is unable to tolerate conditions for radionuclide imaging.
Beschreibung

radionuclide imaging

Datentyp

boolean

Alias
UMLS CUI [1]
C0034606
5. subject has been administered another radiopharmaceutical that would interfere with the assessment of technetium tc 99m ec20.
Beschreibung

technetium tc 99m ec20

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0182638
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C1883272

Ähnliche Modelle

Eligibility Metastatic Renal Cell Carcinoma NCT01689662

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
1. subject must be 18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
metastatic renal cell carcinoma
Item
2. subject must have known or strongly suspected metastatic renal cell carcinoma with at least one target lesion as identified by ultrasonography, mri, or ct.
boolean
C0278678 (UMLS CUI [1])
kidney function
Item
3. subject must have good kidney function.
boolean
C0232804 (UMLS CUI [1])
written informed
Item
4. subject must provide written informed consent prior to enrollment.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnancy or breast-feeding
Item
1. subject is pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
participating in another study
Item
2. subject is simultaneously participating in another investigational drug study, excluding the follow-up phase.
boolean
C2348568 (UMLS CUI [1])
investigational agent
Item
3. subject has received an investigational agent within 7 days prior to enrollment.
boolean
C1875319 (UMLS CUI [1])
radionuclide imaging
Item
4. subject is unable to tolerate conditions for radionuclide imaging.
boolean
C0034606 (UMLS CUI [1])
technetium tc 99m ec20
Item
5. subject has been administered another radiopharmaceutical that would interfere with the assessment of technetium tc 99m ec20.
boolean
C0182638 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C1883272 (UMLS CUI [1,3])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video